-
公开(公告)号:US07897622B2
公开(公告)日:2011-03-01
申请号:US11837202
申请日:2007-08-10
申请人: Pierre Beaulieu , René Coulombe , Gulrez Fazal , Sylvie Goulet , Martin Poirier , Jean Rancourt , Tim Stammers , Bounkham Thavonekham
发明人: Pierre Beaulieu , René Coulombe , Gulrez Fazal , Sylvie Goulet , Martin Poirier , Jean Rancourt , Tim Stammers , Bounkham Thavonekham
IPC分类号: C07D211/84 , A61K31/44
CPC分类号: C07D213/68 , C07D213/70 , C07D213/71 , C07D213/73 , C07D213/74 , C07D213/79 , C07D213/80 , C07D213/85 , C07D213/89 , C07D215/227 , C07D217/24 , C07D231/18 , C07D235/08 , C07D235/12 , C07D237/14 , C07D239/34 , C07D239/56 , C07D241/20 , C07D241/24 , C07D307/20 , C07D309/12 , C07D333/32 , C07D401/04 , C07D401/06 , C07D401/12 , C07D405/12 , C07D413/06 , C07D413/12 , C07D417/06 , C07D417/12 , C07D471/04
摘要: Compounds of formula I: wherein X, R2, R3, R5 and R6 are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase.
摘要翻译: 式I化合物:其中X,R 2,R 3,R 5和R 6在本文中定义,可用作丙型肝炎病毒NS5B聚合酶的抑制剂。
-
公开(公告)号:US20080045516A1
公开(公告)日:2008-02-21
申请号:US11837202
申请日:2007-08-10
申请人: Pierre Beaulieu , Rene Coulombe , Gulrez Fazal , Sylvie Goulet , Martin Poirier , Jean Rancourt , Timothy Stammers , Bounkham Thavonekham
发明人: Pierre Beaulieu , Rene Coulombe , Gulrez Fazal , Sylvie Goulet , Martin Poirier , Jean Rancourt , Timothy Stammers , Bounkham Thavonekham
IPC分类号: A61K31/4523 , A61K31/341 , A61K31/351 , A61K31/4152 , A61K31/4184 , A61K31/47 , A61K31/513 , A61K31/541 , C07D213/68 , C07D401/04 , C07D309/10 , C07D307/20 , C07D241/18 , C07D239/34 , C07D235/04 , C07D231/18 , C07D217/24 , C07D215/227 , C07D417/06 , C07D413/04 , C07D401/06 , A61P31/12 , A61K31/5377 , A61K31/4965 , A61K31/4545 , A61K31/4412 , A61K31/4439 , A61K31/444
CPC分类号: C07D213/68 , C07D213/70 , C07D213/71 , C07D213/73 , C07D213/74 , C07D213/79 , C07D213/80 , C07D213/85 , C07D213/89 , C07D215/227 , C07D217/24 , C07D231/18 , C07D235/08 , C07D235/12 , C07D237/14 , C07D239/34 , C07D239/56 , C07D241/20 , C07D241/24 , C07D307/20 , C07D309/12 , C07D333/32 , C07D401/04 , C07D401/06 , C07D401/12 , C07D405/12 , C07D413/06 , C07D413/12 , C07D417/06 , C07D417/12 , C07D471/04
摘要: Compounds of formula I: wherein X, R2, R3, R5 and R6 are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase.
摘要翻译: 式I化合物:其中X,R 2,R 3,R 5和R 6是本文定义的 可用作丙型肝炎病毒NS5B聚合酶的抑制剂。
-
公开(公告)号:US20060160798A1
公开(公告)日:2006-07-20
申请号:US11333163
申请日:2006-01-17
申请人: Pierre Beaulieu , Gulrez Fazal , Sylvie Goulet , George Kukolj , Martin Poirier , Youla Tsantrizos , Eric Jolicoeur , James Gillard , Marc-Andre Poupart
发明人: Pierre Beaulieu , Gulrez Fazal , Sylvie Goulet , George Kukolj , Martin Poirier , Youla Tsantrizos , Eric Jolicoeur , James Gillard , Marc-Andre Poupart
IPC分类号: A61K31/5377 , A61K31/4439 , A61K31/454 , A61K31/427 , C07D417/14
CPC分类号: C07D333/62 , C07D209/08 , C07D209/30 , C07D209/42 , C07D401/04 , C07D403/04 , C07D405/04 , C07D409/04 , C07D413/04 , C07D417/04 , C07D471/04
摘要: An isomer, enantiomer, diastereoisomer or tautomer of a compound, represented by formula I: wherein: A is O, S, NR1, or CR1, wherein R1 is defined herein; represents either a single or a double bond; R2 is selected from 6 or 10-membered aryl and Het, each optionally substituted with R20; provided that Het is not a 5- or 6-membered monocyclic heterocycle having 1 or 2 nitrogen heteroatoms; B is NR3 or CR3, with the proviso that one of A or B is either CR1 or CR3, wherein R3 is defined herein; K is N or CR4, wherein R4 is defined herein; L is N or CR5, wherein R5 has the same definition as R4; M is N or CR7, wherein R7 has the same definition as R4; Y1 is O or S; Z is N(R6a)R6 or OR6, wherein R6a is H or alkyl or NR61R62 wherein R61 and R62 are defined herein; and R6 is H, alkyl, cycloalkyl, alkenyl, Het, alkyl-aryl, alkyl-Het; or R6 is wherein R7 and R8 and Q are as defined herein; Y2 is O or S; R9 is H, (C1-6 alkyl), (C3-7)cycloalkyl or (C1-6)alkyl-(C3-7)cycloalkyl, aryl, Het, (C1-6)alkyl-aryl or (C1-6)alkyl-Het, all of which optionally substituted with R90; or R9 is covalently bonded to either of R7 or R8 to form a 5- or 6-membered heterocycle; a salt or a derivative thereof, as an inhibitor of HCV NS5B polymerase.
-
公开(公告)号:US07879851B2
公开(公告)日:2011-02-01
申请号:US12372533
申请日:2009-02-17
申请人: Youla S. Tsantrizos , Catherine Chabot , Pierre Beaulieu , Christian Brochu , Martin Poirier , Timothy A. Stammers , Bounkham Thavonekham , Jean Rancourt
发明人: Youla S. Tsantrizos , Catherine Chabot , Pierre Beaulieu , Christian Brochu , Martin Poirier , Timothy A. Stammers , Bounkham Thavonekham , Jean Rancourt
IPC分类号: A61K31/5377 , A61K31/4439 , A61K31/4184 , C07D413/14 , C07D401/14 , C07D235/04
CPC分类号: C07D487/04 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/04
摘要: An enantiomer, diastereoisomer or tautomer of a compound, represented by formula I: wherein A, B, R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 are as defined herein, or a salt or ester thereof, as an inhibitor of HCV NS5B polymerase.
摘要翻译: 由式I表示的化合物的对映体,非对映异构体或互变异构体:其中A,B,R 1,R 2,R 3,R 4,R 5,R 6,R 7,R 8,R 9和R 10如本文所定义, 作为HCV NS5B聚合酶的抑制剂。
-
公开(公告)号:US08030309B2
公开(公告)日:2011-10-04
申请号:US12891112
申请日:2010-09-27
申请人: Youla S. Tsantrizos , Catherine Chabot , Pierre Beaulieu , Christian Brochu , Martin Poirier , Timothy A. Stammers , Bounkham Thavonekham , Jean Rancourt
发明人: Youla S. Tsantrizos , Catherine Chabot , Pierre Beaulieu , Christian Brochu , Martin Poirier , Timothy A. Stammers , Bounkham Thavonekham , Jean Rancourt
IPC分类号: A61K31/501 , A61K31/497 , A61K31/4427 , C07D401/14 , C07D413/14
CPC分类号: C07D487/04 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/04
摘要: An enantiomer, diastereoisomer or tautomer of a compound, represented by formula I: wherein A, B, R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 are as defined herein, or a salt or ester thereof, as an inhibitor of HCV NS5B polymerase.
-
公开(公告)号:US20050222236A1
公开(公告)日:2005-10-06
申请号:US11062305
申请日:2005-02-18
申请人: Youla Tsantrizos , Catherine Chabot , Pierre Beaulieu , Christian Brochu , Martin Poirier , Timothy Stammers , Bounkham Thavonekham , Jean Rancourt
发明人: Youla Tsantrizos , Catherine Chabot , Pierre Beaulieu , Christian Brochu , Martin Poirier , Timothy Stammers , Bounkham Thavonekham , Jean Rancourt
IPC分类号: A61K31/4184 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D487/04 , C07D43/02
CPC分类号: C07D487/04 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/04
摘要: An enantiomer, diastereoisomer or tautomer of a compound, represented by formula I: wherein A, B, R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 are as defined herein, or a salt or ester thereof, as an inhibitor of HCV NS5B polymerase.
摘要翻译: 由式I表示的化合物的对映体,非对映异构体或互变异构体:其中A,B,R 1,R 2,R 3, R 4,R 5,R 6,R 7,R 8, R 9和R 10如本文所定义,或其盐或酯作为HCV NS5B聚合酶的抑制剂。
-
公开(公告)号:US07241801B2
公开(公告)日:2007-07-10
申请号:US11182987
申请日:2005-07-15
申请人: Pierre Beaulieu , Christian Brochu , Stephen Kawai , Jean Rancourt , Timothy A. Stammers , Bounkham Thavonekham , Youla S. Tsantrizos
发明人: Pierre Beaulieu , Christian Brochu , Stephen Kawai , Jean Rancourt , Timothy A. Stammers , Bounkham Thavonekham , Youla S. Tsantrizos
IPC分类号: A61K31/404 , A61K31/4155 , A61K31/427 , A61K31/4427 , A61K31/497 , C07D209/12 , C07D209/14
CPC分类号: C07D403/04 , C07D209/08 , C07D209/12 , C07D401/04 , C07D401/14 , C07D405/04 , C07D405/14 , C07D409/04 , C07D417/04
摘要: A compound, represented by formula (I): wherein A, B, R1, R2, R3, R5, R6, R7, R9, and R10 are as defined herein, or an enantiomer, diastereoisomer or tautomer thereof, including a salt, ester or derivative thereof, as an inhibitor of HCV NS5B polymerase.
摘要翻译: 由式(I)表示的化合物:其中A,B,R 1,R 2,R 3,R 5, R 6,R 6,R 9,R 9和R 10如本文所定义, 或其对映体,非对映异构体或互变异构体,包括其盐,酯或衍生物,作为HCV NS5B聚合酶的抑制剂。
-
公开(公告)号:US07582770B2
公开(公告)日:2009-09-01
申请号:US11062305
申请日:2005-02-18
申请人: Youla S. Tsantrizos , Catherine Chabot , Pierre Beaulieu , Christian Brochu , Timothy A. Stammers , Bounkham Thavonekham , Jean Rancourt
发明人: Youla S. Tsantrizos , Catherine Chabot , Pierre Beaulieu , Christian Brochu , Timothy A. Stammers , Bounkham Thavonekham , Jean Rancourt
IPC分类号: C07D235/04 , C07D487/00 , C07D233/02 , C07D207/00 , C07D209/04 , A61K31/415 , A61K31/40 , A61K31/405
CPC分类号: C07D487/04 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/04
摘要: An enantiomer, diastereoisomer or tautomer of a compound, represented by formula I: wherein A, B, R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 are as defined herein, or a salt or ester thereof, as an inhibitor of HCV NS5B polymerase.
摘要翻译: 由式I表示的化合物的对映异构体,非对映异构体或互变异构体:其中A,B,R1,R2,R3,R4,R5,R6,R7,R8,R9和R10如本文所定义,或盐或酯 作为HCV NS5B聚合酶的抑制剂。
-
公开(公告)号:US20060052418A1
公开(公告)日:2006-03-09
申请号:US11182987
申请日:2005-07-15
申请人: Pierre Beaulieu , Christian Brochu , Stephen Kawai , Jean Rancourt , Timothy Stammers , Bounkham Thavonekham , Youla Tsantrizos
发明人: Pierre Beaulieu , Christian Brochu , Stephen Kawai , Jean Rancourt , Timothy Stammers , Bounkham Thavonekham , Youla Tsantrizos
IPC分类号: A61K31/4439 , A61K31/427 , A61K31/404 , C07D417/02 , C07D405/02 , C07D409/02
CPC分类号: C07D403/04 , C07D209/08 , C07D209/12 , C07D401/04 , C07D401/14 , C07D405/04 , C07D405/14 , C07D409/04 , C07D417/04
摘要: A compound, represented by formula (I): wherein A, B, R1, R2, R3, R5, R6, R7, R9, and R10 are as defined herein, or an enantiomer, diastereoisomer or tautomer thereof, including a salt, ester or derivative thereof, as an inhibitor of HCV NS5B polymerase.
摘要翻译: 由式(I)表示的化合物:
-
公开(公告)号:US20060293306A1
公开(公告)日:2006-12-28
申请号:US11464651
申请日:2006-08-15
申请人: Pierre Beaulieu , Gulrez Fazal , George Kukolj , Eric Jolicoeur , James Gillard , Marc-Andre Poupart , Jean Rancourt
发明人: Pierre Beaulieu , Gulrez Fazal , George Kukolj , Eric Jolicoeur , James Gillard , Marc-Andre Poupart , Jean Rancourt
IPC分类号: A61K31/55 , A61K31/541 , A61K31/5377 , A61K31/53 , A61K31/496 , A61K31/4745 , C07D471/02
CPC分类号: C07D333/62 , C07D209/08 , C07D209/30 , C07D209/42 , C07D401/04 , C07D403/04 , C07D405/04 , C07D409/04 , C07D413/04 , C07D417/04 , C07D471/04
摘要: An isomer, enantiomer, diastereoisomer, or tautomer of a compound, represented by formula I: wherein: A is O, S, NR1, or CR1, wherein R1 is defined herein; — represents either a single or a double bond; R2 is selected from: H, halogen, R21, OR21, SR21, COOR21, SO2N(R22)2, N(R22)2, CON(R22)2, NR22C(O)R22 or NR22C(O)NR22 wherein R21 and each R22 is defined herein; B is NR3 or CR3, with the proviso that one of A or B is either CR1 or CR3, wherein R3 is defined herein; K is N or CR4, wherein R4 is defined herein; L is N or CR5 wherein R5 has the same definition as R4 defined above; M is N or CR7, wherein R7 has the same definition as R4 defined above; Y1 is O or S; Z is N(R6a)R6 or OR6, wherein R6a is H or alkyl or NR61R62 wherein R61 and R62 are defined herein; a salt or a derivative thereof, as an inhibitor of HCV NS5B polymerase.
摘要翻译: 由式I表示的化合物的异构体,对映异构体,非对映异构体或互变异构体:其中:A是O,S,NR 1或CR 1,其中R 1, SUP> 1 SUP>在本文中定义; - 表示单键或双键; R 2选自:H,卤素,R 21,或21,SR 21,COOR, > 21,SO 2 N(R 22)2,N(R 22) CON(R 22)2,NR 22,C(O)R 22, >或NR 22其中R 21和R 22各自在本文中定义:其中R 21和/ B是NR 3或CR 3,条件是A或B中的一个是CR 1或CR 3, SUP>,其中R 3 3定义在本文中; K为N或CR 4,其中R 4为本文定义的; L是N或CR 5,其中R 5具有与上述定义的R 4相同的定义; M是N或CR 7,其中R 7具有与上述定义的R 4相同的定义; Y 1是O或S; Z是N(R 6a)R 6或OR 6,其中R 6a是H或烷基或NR 其中R 61和R 62在本文中定义;其中R 61和/ 其盐或其衍生物,作为HCV NS5B聚合酶的抑制剂。
-
-
-
-
-
-
-
-
-